Liver Disease Diagnosis and Treatment
Liver Disease Diagnosis and Treatment is a research topic within Epidemiology. Science Explorer counts 122k research works in it since 1950. 16.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, diagnosis, management, and pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). It covers topics such as liver fibrosis, insulin resistance, hepatic steatosis, metabolic syndrome, nonalcoholic steatohepatitis (NASH), and non-invasive assessment methods. The papers also discuss the association of NAFLD with hepatocellular carcinoma and its impact on public health.
- NAFLD
- NASH
- Liver Fibrosis
- Insulin Resistance
- Hepatic Steatosis
- Liver Biopsy
- Metabolic Syndrome
- Fatty Liver
- Hepatocellular Carcinoma
- Non-invasive Assessment
- Research works
- 122k fractional, since 1950
- In the world top 10%
- 21k per year above
- Top-10% rate
- 16.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +32% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Liver Disease Diagnosis and Treatment research?
By volume, China and the United States publish the most (5.7k and 4.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 5.7k works
- 2 United States 4.1k works
- 3 India 1.9k works
- 4 Japan 936 works
- 5 Italy 837 works
- 6 South Korea 809 works
- 7 Egypt 803 works
- 8 United Kingdom 760 works
- 9 Germany 679 works
- 10 Spain 543 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Liver Disease Diagnosis and Treatment research?
By volume in 2022–2025, Ain Shams University publishes the most Liver Disease Diagnosis and Treatment research, followed by Sun Yat-sen University and Capital Medical University.
By volume, 2022–2025
- 1 Ain Shams UniversityEgypt 126 works
- 2 Sun Yat-sen UniversityChina 88 works
- 3 Capital Medical UniversityChina 82 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 80 works
- 5 Sichuan UniversityChina 69 works
- 6 Cairo UniversityEgypt 64 works
- 7 Peking UniversityChina 62 works
- 8 Shanghai Jiao Tong UniversityChina 62 works
- 9 Menoufia UniversityEgypt 60 works
- 10 Post Graduate Institute of Medical Education and ResearchIndia 60 works
Who are the leading researchers in Liver Disease Diagnosis and Treatment?
The most-cited researchers publishing on Liver Disease Diagnosis and Treatment include Patrick M. Bossuyt, Mark J. Daly and Paulo A. Lotufo.
- 1 Patrick M. Bossuyt Netherlands 14k citations
- 2 Mark J. Daly United States 9.6k citations
- 3 Paulo A. Lotufo Brazil 7.2k citations
- 4 Walter C. Willett United States 6.8k citations
- 5 Reza Malekzadeh Iran 6.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Liver Disease Diagnosis and Treatment research done?
The largest centres of Liver Disease Diagnosis and Treatment research in 2022–2025 are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Shibīn al Kawm.
Largest cities, 2022–2025
Where it is the local speciality
- Shibīn al KawmEG · 62.8 works11×
Location quotient: how much more of its research is in Liver Disease Diagnosis and Treatment than the world average.
Where is the best place to study Liver Disease Diagnosis and Treatment?
Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine and Menoufia University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chengdu University of Traditional Chinese MedicineChina | 62.2 | 49.4% | 7.2× | 39 | +26.6% |
| 2 | Shanghai University of Traditional Chinese MedicineChina | 61.3 | 31.9% | 11.4× | 53 | +17.1% |
| 3 | Menoufia UniversityEgypt | 60.9 | 6.8% | 10.7× | 60 | +256.3% |
| 4 | University of Medicine and Pharmacy of CraiovaRomania | 58.7 | 25.1% | 13.1× | 16 | +215.0% |
| 5 | Guangdong Pharmaceutical UniversityChina | 57.0 | 46.4% | 7.8× | 20 | +31.9% |
| 6 | Virginia Commonwealth UniversityUnited States | 54.7 | 33.0% | 5.9× | 46 | +79.8% |
| 7 | Dalian Medical UniversityChina | 53.6 | 28.8% | 7.3× | 33 | +100.8% |
| 8 | Wenzhou Medical UniversityChina | 53.4 | 37.7% | 5.8× | 48 | +19.5% |
| 9 | Beijing University of Chinese MedicineChina | 53.3 | 37.4% | 7.8× | 33 | -5.8% |
| 10 | Ain Shams UniversityEgypt | 53.2 | 2.5% | 7.3× | 126 | +149.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Liver Disease Diagnosis and Treatment research growing?
Output in 2018–2022 was 32% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Liver Disease Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.